A big drop in this insulin-pump maker may make it the perfect time to add it to your portfolio....…
Insulet (PODD) is now the only insulin pump company to be awarded with both the ISO 27001 and the DTSec…
Einmalzahlung von 50 Mio Franken aus dem ausgelaufenen Vertriebsvertrag mit Insulet....…
In the third quarter, the tubeless insulin pump specialist grew revenue 24% year over year and increased full-year 2018 revenue…
We are encouraged by the year-over-year improvement in Insulets (PODD) Q3 results on solid uptake of Omnipod system in the…
PODD earnings call for the period ending September 30, 2018....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insulet (PODD) delivered earnings and revenue surprises of 50.00% and 1.74%, respectively, for the quarter ended September 2018. Do the…
Fiasps operative efficiency coupled with Insulets (PODD) Omnipod System will provide a new option for both patients and prescribers to…
Insulet (PODD) commences 2018 with favorable reimbursement updates. The company attains several landmarks regarding Omnipods market reach....…
Heres a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Stocks that hit 52-week…
Zacks.com featured highlights include: Entercom, Insulet, ESCO and Tristate...…
The tubeless insulin pump specialists revenue growth slowed notably in the second quarter, but management said this is a short-term…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insulet (PODD) delivered earnings and revenue surprises of 76.92% and -6.52%, respectively, for the quarter ended June 2018. Do the…
Dont be caught off-guard: Insulet (NASDAQ: PODD) releases its next round of earnings Thursday. Want to skip the homework and…
Insulets (PODD) Omnipod has huge market potential in Canada as it is the only tubeless insulin pump sold in the…
Insulets (PODD) goal to begin direct commercial operation in Europe is a year-long endeavor....…
BILLERICA, Massachusetts, USA und LONDON, England--(BUSINESS WIRE)--Die Insulet Corporation (NASDAQ:PODD) (Insulet bzw. die Gesellschaft), führender Anbieter schlauchloser Insulinpumpen mit dem…
Wegen der Beendigung der Zusammenarbeit mit dem US-Insulinpumpenhersteller Insulet verliert die Berner Medizintechnikfirma Ypsomed eine lukrative Einnahmequelle. Künftig will das Unternehmen…
NEW YORK, May 14, 2018 /PRNewswire/ --
If you bought Insulet Corp. common stockfrom May 7,…
In the first quarter, the tubeless insulin pump specialist narrowed its earnings loss more than many investors were likely expecting....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
* INSULET REPORTS FIRST QUARTER 2018 REVENUE OF $123.6
MILLION, UP
21% YEAR-OVER-YEAR, AND GROSS MARGIN OF 61.4%, UP 300 BASIS
POINTS, EXCEEDING…
NEW YORK, May 02, 2018 /PRNewswire/ --
WallStEquities.com strives to bring the best free research to the…
* INSULET ESTABLISHES TWO SIGNIFICANT COMMERCIAL
PARTNERSHIPS TO
SUPPORT ITS EUROPEAN EXPANSION...…
BILLERICA, Mass. und London, UK--(BUSINESS WIRE)--Die Insulet Corporation (NASDAQ:PODD) (Insulet bzw. die Gesellschaft), das führende Unternehmen für schlauchlose Insulinpumpen und…
NEW YORK, March 23, 2018 /PRNewswire/ --
WallStEquities.com strives to bring the best free research to the…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insulet Corporation (NASDAQ: PODD) is up 80.5 percent year-over-year, and even last quarters bottom-line miss cant deter the biotechs bulls.
…
The tubeless insulin pump specialist capped off a strong 2017 with a solid fourth quarter....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insulet (NASDAQ: PODD) releases its next round of earnings Wednesday. Get the latest predictions in Benzingas essential guide to the…
NEW YORK, Feb. 1, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. …
BASEL, Switzerland, January 9, 2018 /PRNewswire/ --
Ascensia Diabetes Care today announced it has expanded the scope…
* ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH
INSULET
CORPORATION BY SIGNING COMMERCIAL AGREEMENT...…
Shares soar after management announced a big reimbursement win....…
Raymond James identified four major tailwinds for Insulet Corporation (NASDAQ: PODD) that the firm said could help drive…
DUBLIN, November 21, 2017 /PRNewswire/ --
The "United States Insulin Delivery Devices Market Outlook 2017: Key Product…
NEW YORK, November 15, 2017 /PRNewswire/ --
If you want a Stock Review on PODD, GKOS, WST,…
* Insulet announces pricing of convertible senior notes due
2024...…
Ringing today's closing bells are Radian Group with CEO Rick Thornberry celebrating their 25th anniversary of listing and 40th anniversary…
Shares leap after the company reports expectation-smashing results....…
The drug delivery specialists key metrics continued to move in the right direction in the third quarter....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEW YORK, Oct. 24, 2017 /PRNewswire/ --
AcelRx Pharmaceuticals, Inc. (ACRX)
Lifshitz & Miller…
BILLERICA, Mass.--(BUSINESS WIRE)--Die Insulet Corporation (NASDAQ:PODD) (Insulet oder das Unternehmen), der führende Anbieter schlauchloser Insulinpumpen-Technologie, hat heute auf dem Kongress…
NEW YORK, September 7, 2017 /PRNewswire/ --
If you want a Stock Review on PODD, MBOT, BCR,…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Die auf Diabetesmedikamente spezialisierte Ypsomed schockt im Juli die Anleger mit dem Verlust des wichtigen Insulet-Geschäfts. War die darauf folgende…